Small Talk: Sinclair boosts portfolio with £21m Advanced Bio-Technologies deal

Sinclair Pharma and IS Pharma agreed to merge in April, with shares in the combined business (imaginatively christened Sinclair IS Pharma) starting trading in late May. Since then, the stock has been under pressure, easing as volatility in the wider market gathered pace. But the share price received a shot in the arm last week, after the company, which specialises in dermatological and wound care treatments, unveiled plans to buy the privately held US biotech company, Advanced Bio-Technologies (ABT).

The £21m cash and share deal, which has been structured to exclude ABT's US business, will boost Sinclair's suite of skincare products. The main offering is its Kelo-cote scar treatment, which will become Sinclair's second largest brand after Flammazine.

Sinclair gets ownership of the flagship (and high margin) product in all markets outside the US. Since it wasalready licensed for Kelo-cote in its core European markets, the deal opens up fast growing countries such as Brazil, Korea and China. In all, ABT's international business delivered revenues of $6.1m last year. That works out to growth of 19 per cent on the year before. And things are looking up.

"Based on the results in the first ten months of the current financial year to [the end of October], ABT's international revenues are expected to grow by approximately 40 per cent by the end of 2011, including revenues from Sinclair IS in Europe," the company said when it unveiled the deal on 8 December. Looking more closely at Kelo-cote, Sinclair said the treatment already has a foothold in Brazil, with the country, which will serve as a springboard for expansion into other Latin American markets, generating around $2m in revenues. On the other side of the world, in Asia, Kelo-cote boasts $1.1m in revenues in South Korea. It is also sold in other countries in the region, including China.

It's also worth noting that ABT has been pushing the treatment quite strongly in terms of marketing. This means that while Sinclair is looking to bolster the efforts, it will only need two additional staff to fulfil its ambitions in that regard.

The reaction in the markets was certainly positive, with the stock up 10 per cent since the announcement. The City was also welcoming. Pointing to Kelo-cote, Finncap analysts said the deal was essentially an "asset purchase". "We estimate that the incremental Kelo-cote revenues in the year ending June 2013 will be of the order of $8m," they said.

"This is a high gross margin product (we estimate more than 70 per cent) and the incremental costs (sales, marketing and shipping) we estimate will be about $1m... the net contribution to the bottom line will of the order of $4m."

Their counterparts at Singer Capital Markets added that the deal, which comes after Sinclair sold off its Mysoline epilepsy treatment, fitted with the company's strategy of focusing on its core areas.

"We note that the company has successfully recycled income from the divestment of Mysoline (a less attractive portfolio product) in order to fund this acquisition," Singer said.

Start your day with The Independent, sign up for daily news emails
Voices
Barn owls are among species that could be affected
charity appeal
News
Sarah Silverman (middle) with sister Reform Rabbi Susan Silverman (right) and sister actress Laura Silverman (left) at Jerusalem's Western Wall for feminist Hanuka candle-lighting ceremony
peopleControversial comedian stages pro-equality Hanukkah lighting during a protest at Jerusalem's Wailing Wall
Arts and Entertainment
The Bach Choir has been crowned the inaugural winner of Sky Arts’ show The Great Culture Quiz
arts + ents140-year-old choir declared winner of Sky Arts' 'The Great Culture Quiz'
Sport
After another poor series in Sri Lanka, Alastair Cook claimed all players go through a lean period
cricketEoin Morgan reportedly to take over ODI captaincy
PROMOTED VIDEO
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Carlton Senior Appointments: Private Banking Manager - Intl Bank - Los Angeles

$200 - $350 per annum: Carlton Senior Appointments: Managing Producer – Office...

Carlton Senior Appointments: San Fran - Investment Advisor – Ind Advisory Firm

$125 - $225 per annum: Carlton Senior Appointments: San Fran - Investment Advi...

Sheridan Maine: Commercial Finance Manager

Up to £70,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Sheridan Maine: Regulatory Reporting Accountant

Up to £65,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Day In a Page

Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas